SI0993304T1 - Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative - Google Patents

Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative

Info

Publication number
SI0993304T1
SI0993304T1 SI9830431T SI9830431T SI0993304T1 SI 0993304 T1 SI0993304 T1 SI 0993304T1 SI 9830431 T SI9830431 T SI 9830431T SI 9830431 T SI9830431 T SI 9830431T SI 0993304 T1 SI0993304 T1 SI 0993304T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
side effects
acid derivative
hydroxamic acid
reduced side
Prior art date
Application number
SI9830431T
Other languages
Slovenian (sl)
Inventor
Balazs S�MEGI
Original Assignee
N-Gene Research Laboratories Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9701081A external-priority patent/HU9701081D0/en
Application filed by N-Gene Research Laboratories Inc. filed Critical N-Gene Research Laboratories Inc.
Publication of SI0993304T1 publication Critical patent/SI0993304T1/en

Links

SI9830431T 1997-06-23 1998-06-22 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative SI0993304T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9701081A HU9701081D0 (en) 1997-06-23 1997-06-23 Pharmaceutical composition of antitumoral activity
PCT/IB1998/000961 WO1998058676A1 (en) 1997-06-23 1998-06-22 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative
EP98925873A EP0993304B1 (en) 1997-06-23 1998-06-22 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative

Publications (1)

Publication Number Publication Date
SI0993304T1 true SI0993304T1 (en) 2003-10-31

Family

ID=89995269

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830431T SI0993304T1 (en) 1997-06-23 1998-06-22 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative

Country Status (1)

Country Link
SI (1) SI0993304T1 (en)

Similar Documents

Publication Publication Date Title
HK1026373A1 (en) Pharmaceutical compositions having appaetite suppressant activity
HUP0000567A3 (en) Sulfonyl urea derivatives and pharmaceutical compositions thereof inhibiting interleukin-1 activity
HUP0100059A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
HUP0001541A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
ZA991716B (en) Pharmaceutical composition of topiramate.
HUP0100900A3 (en) Pharmaceutically active morpholinol and medicaments containing them
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
HUP0101530A3 (en) Pharmaceutical compositions containing indolyl-3-glyoxylic acid derivatives with antitumoral activity
AP2000001902A0 (en) Aerosolized active agent delivery
HUP0101461A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
AU9297898A (en) Thioalkyl compounds, methods, and compositions for inhibiting parp activity
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
HUP0000965A3 (en) Pyrrolidine derivatives having phospolipase a2 inhibitory activity and pharmaceutical compositions containing the same
HUP0000145A3 (en) Betha-sulfonyl hydroxamic acid derivatives with matrix maetalloproteinases inhibitor activity, use thereof and pharmaceutical compositions containing them
NZ298677A (en) Hydroxamic acid derivatives, preparation and pharmaceutical compositions thereof
HUP0002510A3 (en) Tetrazole derivatives and pharmaceutical compositions containing them
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
HUP0002853A3 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
IL134536A0 (en) Compounds possessing neuronal activity and pharmaceutical compositions containing the same
HUP0102369A3 (en) Amino acid derivatives and drugs containing the same as the active ingredient
HUP0003068A3 (en) Chalcones having antiproliferative activity and pharmaceutical compositions containing them
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
IL136612A (en) Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same
HUP0001940A3 (en) Benzisothiazole derivatives, their use and pharmaceutical compositions containing them